Chronic non-infectious inflammations of the placenta

Česká verze

Authors: Magdaléna Daumová ^1,2; Šárka Hadravská ^1,2; Lenka Planičková ³; Andrea Straková Peteříková ¹
Authors place of work: Šiklův ústav patologie LFP UK a FN Plzeň ¹; Bioptická laboratoř s. r. o., Plzeň ²; Ústav patologie 1. LF UK a VFN v Praze ³
Published in the journal: Čes.-slov. Patol., 57, 2021, No. 4, p. 208-215
Category: Přehledový článek

Summary

In addition to the well-known group of inflammations of infectious etiology, placental inflammations arising on immunological basis are also encountered. The incidence of the latter far exceeds the group of infectious lesions of the placenta caused mainly by microorganisms of the TORCH group.

Given the current knowledge of the possible complications of these inflammations, their precise diagnosis becomes more important not only from the clinicopathological point of view, but also because of potential forensic consequences.

The aim of this article is to provide readers with a basic overview of the morphology, classification, presumed pathogenesis and clinical aspects of these entities.

Keywords:

Chorioamnionitis – Placenta – fetal growth restriction – chronic inflammation – villitis – VUE – deciduitis – intervillositis – FGR – intrauterine fetal demise – IUFD

Zdroje

1. Redline RW. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol 2007; 38(10): 1439-1446.

2. Redline RW, Ravishankar S, Bagby CM, Saab ST, Zarei S. Four major patterns of placental injury: a stepwise guide for understanding and implementing the 2016 Amsterdam consensus. Mod Pathol 2021; 34(6): 1074-1092.

3. Redline RW. Classification of placental lesions. Am J Obstet Gynecol 2015; 213(4 Suppl): S21-28.

4. Chen A, Roberts DJ. Placental pathologic lesions with a significant recurrence risk - what not to miss! APMIS 2018; 126(7): 589-601.

5. Becroft DM, Thompson JM, Mitchell EA. Placental villitis of unknown origin: epidemiologic associations. Am J Obstet Gynecol 2005; 192(1): 264-271.

6. Boog G. Chronic villitis of unknown etiology. Eur J Obstet Gynecol Reprod Biol 2008; 136(1): 9-15.

7. Nowak C, Joubert M, Jossic F, et al. Perinatal prognosis of pregnancies complicated by placental chronic villitis or intervillositis of unknown etiology and combined lesions: About a series of 178 cases. Placenta 2016; 44: 104- 108.

8. Derricott H, Jones RL, Greenwood SL, Batra G, Evans MJ, Heazell AE. Characterizing Villitis of Unknown Etiology and Inflammation in Stillbirth. Am J Pathol 2016; 186(4): 952-961.

9. Tamblyn JA, Lissauer DM, Powell R, Cox P, Kilby MD. The immunological basis of villitis of unknown etiology - review. Placenta 2013; 34(10): 846-855.

10. Perni SC, Predanic M, Cho JE, Baergen RN. Placental pathology and pregnancy outcomes in donor and non-donor oocyte in vitro fertilization pregnancies. J Perinat Med 2005; 33(1): 27-32.

11. Leon-Garcia SM, Roeder HA, Nelson KK, et al. Maternal obesity and sex-specific differences in placental pathology. Placenta 2016; 38: 33-40.

12. Kim CJ, Romero R, Chaemsaithong P, Kim JS. Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance. Am J Obstet Gynecol 2015; 213(4 Suppl): S53-69.

13. Myerson D, Parkin RK, Benirschke K, Tschetter CN, Hyde SR. The pathogenesis of villitis of unknown etiology: analysis with a new conjoint immunohistochemistry-in situ hybridization procedure to identify specific maternal and fetal cells. Pediatr Dev Pathol 2006; 9(4): 257-265.

14. Redline RW, Patterson P. Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells. Am J Pathol 1993; 143(2): 473-479.

15. Verdijk RM, Kloosterman A, Pool J, et al. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood 2004; 103(5): 1961-1964.

16. Kinder JM, Turner LH, Stelzer IA, et al. CD8(+) T Cell Functional Exhaustion Overrides Pregnancy-Induced Fetal Antigen Alloimmunization. Cell reports 2020; 31(12): 107784.

17. Tsuda S, Nakashima A, Shima T, Saito S. New Paradigm in the Role of Regulatory T Cells During Pregnancy. Frontiers in immunology 2019; 10): 573.

18. Jorgensen N, Persson G, Hviid TVF. The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer. Frontiers in immunology 2019; 10): 911.

19. Katzman PJ, Murphy SP, Oble DA. Immunohistochemical analysis reveals an influx of regulatory T cells and focal trophoblastic STAT-1 phosphorylation in chronic villitis of unknown etiology. Pediatr Dev Pathol 2011; 14(4): 284-293.

20. Khong TY, Mooney EE, Ariel I, et al. Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement. Arch Pathol Lab Med 2016; 140(7): 698-713.

21. Parast M. Chronic Villitis/Villitis of Unknown Etiology. In: Redline RW, Boyd TK, Roberts DJ, eds. Placental and Gestational Pathology (Diagnostic Pediatric Pathology. Cambridge: Cambridge University Press; 2017: 137-144.

22. Redline RW, Ariel I, Baergen RN, et al. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2004; 7(5): 443-452.

23. Redline RW. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol 2005; 192(2): 452-457.

24. Ernst LM, Linn RL, Minturn L, Miller ES. Placental Pathologic Associations With Morbidly Adherent Placenta: Potential Insights Into Pathogenesis. Pediatr Dev Pathol 2017; 20(5): 387-393.

25. Katzman PJ, Blitman J, Metlay LA. Basal Chronic Villitis and Disorders of the Placental Basal Plate: A Possible Immunological Link Between Hypertensive Disorders of Pregnancy and Morbidly Adherent Placenta. Pediatr Dev Pathol 2019; 22(4): 334-339.

26. Kim CJ, Romero R, Kusanovic JP, et al. The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth. Mod Pathol 2010; 23(7): 1000-1011.

27. Gersell DJ, Phillips NJ, Beckerman K. Chronic chorioamnionitis: a clinicopathologic study of 17 cases. Int J Gynecol Pathol 1991; 10(3): 217-229.

28. Jacques SM, Qureshi F. Chronic chorioamnionitis: a clinicopathologic and immunohistochemical study. Hum Pathol 1998; 29(12): 1457-1461.

29. Lee J, Romero R, Xu Y, et al. Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection. Am J Reprod Immunol 2011; 66(6): 510-526.

30. Maymon E, Romero R, Bhatti G, et al. Chronic inflammatory lesions of the placenta are associated with an up-regulation of amniotic fluid CXCR3: A marker of allograft rejection. J Perinat Med 2018; 46(2): 123-137.

31. Heerema-McKenney A, Popek EJ, De Paepe M. Diagnostic Pathology: Placenta (2nd Edition). Philadelphia, PA: Elsevier; 2019: 146-167.

32. Jacques S, Quereshi F. Chronic Inflammatory Lesions Sometimes Associated with Villitis of Unknown Etiology (VUE). In: Redline RW, Boyd TK, Roberts DJ, eds. Placental and Gestational Pathology (Diagnostic Pediatric Pathology. Cambridge: Cambridge University Press; 2017: 145-151.

33. Khong TY, Bendon RW, Qureshi F, et al. Chronic deciduitis in the placental basal plate: definition and interobserver reliability. Hum Pathol 2000; 31(3): 292-295.

34. Kraus FT, Redline RW, Gersell DJ, Nelson DM, Dicke JM. Inflammation and infection. In: Kaplan CG. Placental Pathology: Atlas of Non-tumor Pathology (First Series, Fascicle 3). Wahington (DC): American Registry of Pathology; 2004: 75-115.

35. Redline RW, Zaragoza M, Hassold T. Prevalence of developmental and inflammatory lesions in nonmolar first-trimester spontaneous abortions. Hum Pathol 1999; 30(1): 93-100.

36. Lee JY, Hong JS, Kim EN, et al. Placental C4d as a common feature of chromosomally normal and abnormal miscarriages. Virchows Arch 2014; 464(5): 613-620.

37. Gundogan F, Bianchi DW, Scherjon SA, Roberts DJ. Placental pathology in egg donor pregnancies. Fertil Steril 2010; 93(2): 397-404.

38. Maroun LL, Mathiesen L, Hedegaard M, Knudsen LE, Larsen LG. Pathologic evaluation of normal and perfused term placental tissue. Pediatr Dev Pathol 2014; 17(5): 330-338.

39. Stevens DU, de Nobrega Teixeira JA, Spaanderman MEA, Bulten J, van Vugt JMG, Al-Nasiry S. Understanding decidual vasculopathy and the link to preeclampsia: A review. Placenta 2020; 97: 95-100.

40. Fraser RB, Wright JR, Jr. Eosinophilic/T-cell chorionic vasculitis. Pediatr Dev Pathol 2002; 5(4): 350-355.

41. Jacques SM, Qureshi F, Kim CJ, et al. Eosinophilic/ T-cell chorionic vasculitis: a clinicopathologic and immunohistochemical study of 51 cases. Pediatr Dev Pathol 2011; 14(3): 198-205.

42. Katzman PJ, Oble DA. Eosinophilic/T-cell chorionic vasculitis and chronic villitis involve regulatory T cells and often occur together. Pediatr Dev Pathol 2013; 16(4): 278-291.

43. Katzman PJ. Chorionic Plate Chronic Inflammatory Lesions Including Eosinophilic/T-cell Chorionic Vasculitis. In: Khong TY, Mooney EE, Nikkels PGJ, Morgan TK, Gordijn SJ., eds. Pathology of the Placenta. A Practical Guide. Springer, Cham: Springer Nature Switzerland AG; 2019: 109-113.

44. Katzman PJ, Li L, Wang N. Identification of Fetal Inflammatory Cells in Eosinophilic/T-cell Chorionic Vasculitis Using Fluorescent In Situ Hybridization. Pediatr Dev Pathol 2015; 18(4): 305-309.

45. Katzman PJ, Oble DA. Eosinophilic/T-cell chorionic vasculitis and chronic villitis involve regulatory T cells and often occur together. Pediatr Dev Pathol 2013; 16(4): 278-291.

46. Boyd TK, Redline RW. Chronic histiocytic intervillositis: a placental lesion associated with recurrent reproductive loss. Hum Pathol 2000; 31(11): 1389-1396.

47. Vardi L, Paterson H, Hung NA. Successful pregnancy following treatment of recurrent chronic histiocytic intervillositis. BMJ case reports 2017; 2017.

48. Mekinian A, Costedoat-Chalumeau N, Masseau A, et al. Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study. Autoimmunity 2015; 48(1): 40-45.

49. Bos M, Nikkels PGJ, Cohen D, et al. Towards standardized criteria for diagnosing chronic intervillositis of unknown etiology: A systematic review. Placenta 2018; 61: 80-88.

50. Revaux A, Mekinian A, Nicaise P, et al. Antiphospholipid syndrome and other autoimmune diseases associated with chronic intervillositis. Arch Gynecol Obstet 2015; 291(6): 1229-1236.

51. Dubruc E, Lebreton F, Giannoli C, et al. Placental histological lesions in fetal and neonatal alloimmune thrombocytopenia: A retrospective cohort study of 21 cases. Placenta 2016; 48: 104-109.

52. Tchakarov A, Coffey A, Tatevian N. Neonatal alloimmune thrombocytopenia associated with massive chronic intervillositis: a case report and review of the literature. Pediatr Dev Pathol 2013; 16(1): 32-34.

53. Marchaudon V, Devisme L, Petit S, Ansart- Franquet H, Vaast P, Subtil D. Chronic histiocytic intervillositis of unknown etiology: clinical features in a consecutive series of 69 cases. Placenta 2011; 32(2): 140-145.

54. Contro E, deSouza R, Bhide A. Chronic intervillositis of the placenta: a systematic review. Placenta 2010; 31(12): 1106-1110.

55. Labarrere CA, Hardin JW, Haas DM, Kassab GS. Chronic villitis of unknown etiology and massive chronic intervillositis have similar immune cell composition. Placenta 2015; 36(6): 681-686.

56. Labarrere CA, Bammerlin E, Hardin JW, Dicarlo HL. Intercellular adhesion molecule-1 expression in massive chronic intervillositis: implications for the invasion of maternal cells into fetal tissues. Placenta 2014; 35(5): 311- 317.

57. Hussein K, Stucki-Koch A, Kreipe H, Feist H. Expression of Toll-Like Receptors in Chronic Histiocytic Intervillositis of the Placenta. Fetal and pediatric pathology 2015; 34(6): 407-412.

58. Reus AD, van Besouw NM, Molenaar NM, et al. An immunological basis for chronic histiocytic intervillositis in recurrent fetal loss. Am J Reprod Immunol 2013; 70(3): 230-237.

59. Freitag L, von Kaisenberg C, Kreipe H, Hussein K. Expression analysis of leukocytes attracting cytokines in chronic histiocytic intervillositis of the placenta. International journal of clinical and experimental pathology 2013; 6(6): 1103-1111.

60. Redline RW. Chronic Histiocytic Intervillositis. In: Redline RW, Boyd TK, Roberts DJ, eds. Placental and Gestational Pathology (Diagnostic Pediatric Pathology). Cambridge: Cambridge University Press; 2017: 152-156.

61. Mooney EE. Chronic Histiocytic Intervillositis. In: Khong TY, Mooney EE, Nikkels PGJ, Morgan TK, Gordijn SJ., eds. Pathology of the Placenta. A Practical Guide. Springer, Cham: Springer Nature Switzerland AG; 2019: 207-211.

62. Parant O, Capdet J, Kessler S, Aziza J, Berrebi A. Chronic intervillositis of unknown etiology (CIUE): relation between placental lesions and perinatal outcome. Eur J Obstet Gynecol Reprod Biol 2009; 143(1): 9-13.

63. Heerema-McKenney A. Defense and infection of the human placenta. APMIS 2018; 126(7): 570-588.

64. Taweevisit M, Sukpan K, Siriaunkgul S, Thorner PS. Chronic histiocytic intervillositis with cytomegalovirus placentitis in a case of hydrops fetalis. Fetal and pediatric pathology 2012; 31(6): 394-400.

65. Ordi J, Ismail MR, Ventura PJ, et al. Massive chronic intervillositis of the placenta associated with malaria infection. Am J Surg Pathol 1998; 22(8): 1006-1011.

66. Carmona-Fonseca J, Arango E, Maestre A. Placental malaria in Colombia: histopathologic findings in Plasmodium vivax and P. falciparum infections. Am J Trop Med Hyg 2013; 88(6): 1093-1101.

67. Hosier H, Farhadian SF, Morotti RA, et al. SARS-CoV-2 infection of the placenta. J Clin Invest 2020; 130(9): 4947-4953.

68. Linehan L, O’Donoghue K, Dineen S, White J, Higgins JR, Fitzgerald B. SARS-CoV-2 placentitis: An uncommon complication of maternal COVID-19. Placenta 2021; 104: 261-266.

69. Schwartz DA, Morotti D. Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARSCoV- 2. Viruses 2020; 12(11).